Suspension Culture of Plant Cells Under Phototrophic Conditions

Industrial Scale Suspension Culture of Living Cells

Volumn 9783527335473, Issue , 2014, Pages 259-292

  Niederkrüger, Holger ^a   Dabrowska Schlepp, Paulina ^a   Schaaf, Andreas ^a  

^a Greenovation Biotech GmbH   (Germany)

Author keywords

Animal derived components; Homologous recombination; Lemna; N glycosylation; Physcomitrella; Plant made pharmaceuticals; Single use

Indexed keywords

GENETIC ENGINEERING; GLYCOSYLATION; SAFETY ENGINEERING;

ANIMAL-DERIVED COMPONENT; CONDITION; HOMOLOGOUS RECOMBINATION; LEMNA; N-GLYCOSYLATION; PHYSCOMITRELLA; PLANT-MADE PHARMACEUTICALS; PLANTS CELLS; SINGLE USE; SUSPENSION CULTURES;

RECOMBINANT PROTEINS;

EID: 84926986250     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527683321.ch08     Document Type: Chapter

References (83)

1. Fraley, R.T., Rogers, S.G., Horsch, R.B., Sanders, P.R. et al. (1983) Expression of bacterial genes in plant cells. Proc. Natl. Acad. Sci. U.S.A., 80, 4803-4807.
2. Waugh, R., Brown, J.W.S., Draper, J., Scott, R. et al. (1991) Plant Genetic Engineering, Plant Biotechnology, vol. 1, Blackie Academic, Glasgow.
3. Sijmons, P.C., Dekker, B.M.M., Schrammeijer, B., Verwoerd, T.C. et al. (1990) Production of correctly processed human serum albumin in transgenic plants. Nat. Biotechnol., 8, 217-221.
4. Hoja, U. and Sonnewald, U. (2001) Molecular Farming in Plants. eLS, John Wiley & Sons, Ltd.
5. Faye, L. and Gomord, V. (2010) Success stories in molecular farming-a brief overview. Plant Biotechnol. J., 8, 525-528.
6. Daniell, H., Streatfield, S.J., and Wycoff, K. (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci., 6, 219-226.
7. Schillberg, S., Twyman, R.M., and Fischer, R. (2005) Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine, 23, 1764-1769.
8. Bethell, D.R. and Huang, J. (2004) Recombinant human lactoferrin treatment for global health issues: iron deficiency and acute diarrhea. Biometals Int. J. Role Met. Ions. Biol. Biochem. Med., 17, 337-342.
9. Landry, N., Ward, B.J., Trépanier, S., Montomoli, E. et al. (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. Plos One, 5, e15559.
10. Engel, P.P. (1968) The induction of biochemical and morphological mutants in the moss Physcomitrella patens. Am. J. Bot., 55, 438-446.
11. Schaefer, D.G. and Zryd, J. (2001) The moss Physcomitrella patens, now and then. Plant Physiol., 127, 1430-1438.
12. Reski, R. (1998) Development, genetics and molecular biology of mosses. Bot. Acta, 111, 1-15.
13. Decker, E.L. and Reski, R. (2004) The moss bioreactor. Curr. Opin. Plant Biol., 7, 166-170.
14. Schaefer, D. (1994) Molecular Genetic Approaches to the Biology of the Moss Physcomitrella patens. PhD Thesis, University of Lausanne.
15. Schaefer, D.G. and Zrÿd, J.-P. (1997) Efficient gene targeting in the moss Physcomitrella patens. Plant J., 11, 1195-1206.
16. Strepp, R., Scholz, S., Kruse, S., Speth, V. et al. (1998) Plant nuclear gene knockout reveals a role in plastid division for the homolog of the bacterial cell division protein FtsZ, an ancestral tubulin. Proc. Natl. Acad. Sci. U.S.A., 95, 4368.
17. Mittmann, F., Brücker, G., Zeidler, M., Repp, A. et al. (2004) Targeted knockout in Physcomitrella reveals direct actions of phytochrome in the cytoplasm. Proc. Natl. Acad. Sci. U.S.A., 101, 13939.
18. Koprivova, A., Meyer, A.J., Schween, G., Herschbach, C. et al. (2002) Functional knockout of the adenosine 5-phosphosulfate reductase gene in Physcomitrella patens revives an old route of sulfate assimilation. J. Biol. Chem., 277, 32195.
19. Egener, T., Granado, J., Guitton, M.C., Hohe, A. et al. (2002) High frequency of phenotypic deviations in Physcomitrella patens plants transformed with a genedisruption library. BMC Plant Biol., 2, 6.
20. Nishiyama, T., Hiwatashi, Y., Sakakibara, K., Kato, M. et al. (2000) Tagged mutagenesis and gene-trap in the moss, Physcomitrella patens by shuttle mutagenesis. DNA Res., 7, 9.
21. Koprivova, A., Stemmer, C., Altmann, F., Hoffmann, A. et al. (2004) Targeted knockouts of Physcomitrella lacking plantspecific immunogenic N-glycans. Plant Biotechnol. J., 2, 517-523.
22. Parsons, J., Altmann, F., Arrenberg, C.K., Koprivova, A. et al. (2012) Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol. J., 10, 851-861.
23. Cove, D. (2005) The moss Physcomitrella patens. Annu. Rev. Genet., 39, 339-358.
24. Egener, T., Granado, J., Guitton, M.-C., Hohe, A. et al. (2002) High frequency of phenotypic deviations in Physcomitrella patens plants transformed with a genedisruption library. BMC Plant Biol., 2, 6.
25. Lang, D., Eisinger, J., Reski, R., and Rensing, S.A. (2005) Representation and high-quality annotation of the Physcomitrella patens transcriptome demonstrates a high proportion of proteins involved in metabolism in mosses. Plant Biol. (Stuttgart), 7, 238-250.
26. Rensing, S., Fritzowsky, D., Lang, D., and Reski, R. (2005) Protein encoding genes in an ancient plant: analysis of codon usage, retained genes and splice sites in a moss, Physcomitrella patens. BMC Genomics, 6, 43.
27. Rensing, S.A., Lang, D., Zimmer, A.D., Terry, A. et al. (2008) The Physcomitrella genome reveals evolutionary insights into the conquest of land by plants. Science, 319, 64-69.
28. Reutter, K. and Reski, R. (1996) Production of a heterologous protein in bioreactor cultures of fully differentiated moss plants. Plant Tissue Cult. Biotechnol., 2, 142-147.
29. Büttner-Mainik, A., Parsons, J., Jérôme, H., Hartmann, A. et al. (2011) Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnol. J., 9, 373-383.
30. Schuster, M., Jost, W., Mudde, G.C., Wiederkum, S. et al. (2007) In vivo glycoengineered antibody with improved lytic potential produced by an innovative nonmammalian expression system. Biotechnol. J., 2, 700-708.
31. Baur, A., Reski, R., and Gorr, G. (2005) Enhanced recovery of a secreted recombinant human growth factor using stabilizing additives and by co-expression of human serum albumin in the moss Physcomitrella patens. Plant Biotechnol. J., 3, 331-340.
32. Schaefer, D., Zryd, J.-P., Knight, C.D., and Cove, D.J. (1991) Stable transformation of the moss Physcomitrella patens. Mol. Gen. Genet., 226, 418-424.
33. Schaefer, D.G., Bisztray, G., and Zryd, J.-P. (1994) Genetic Transformation of the Moss, Physcomitrella patens, in Plant Protoplasts and Genetic Engineering, Springer Verlag, pp. 349-364.
34. Jost, W., Link, S., Horstmann, V., Decker, E.L. et al. (2005) Isolation and characterisation of three moss-derived betatubulin promoters suitable for recombinant expression. Curr. Genet., 47, 111-120.
35. Horstmann, V., Huether, C., Jost, W., Reski, R. et al. (2004) Quantitative promoter analysis in Physcomitrella patens: a set of plant vectors activating gene expression within three orders of magnitude. BMC Biotechnol., 4, 13.
36. Weise, A., Rodriguez-Franco, M., Timm, B., Hermann, M. et al. (2006) Use of Physcomitrella patens actin 50 regions for high transgene expression: importance of 50 introns. Appl. Microbiol. Biotechnol., 70, 337-345.
37. Schaaf, A., Reski, R., and Decker, E.L. (2004) A novel aspartic proteinase is targeted to the secretory pathway and to the vacuole in the moss Physcomitrella patens. Eur. J. Cell Biol., 83, 145-152.
38. Schaaf, A., Tintelnot, S., Baur, A., Reski, R. et al. (2005) Use of endogenous signal sequences for transient production and efficient secretion by moss(Physcomitrella patens) cells. BMC Biotechnol., 5, 30.
39. Kasahara, M., Kagawa, T., Sato, Y., Kiyosue, T. et al. (2004) Phototropins mediate blue and red light-induced chloroplast movements in Physcomitrella patens. Plant Physiol., 135, 1388-1397.
40. Schaefer, D., Zryd, J.P., Knight, C.D., and Cove, D.J. (1991) Stable transformation of the moss Physcomitrella patens. Mol. Gen. Genet., 226, 418-424.
41. Schulte, J. and Reski, R. (2004) High throughput cryopreservation of 140,000 Physcomitrella patens mutants. Plant Biol. (Stuttgart), 6, 119-127.
42. Decker, E. and Reski, R. (2012) Glycoprotein production in moss bioreactors. Plant Cell Rep., 31, 453-460.
43. Hohe, A., Decker, E., Gorr, G., Schween, G. et al. (2002) Tight control of growth and cell differentiation in photoautotrophically growing moss (Physcomitrella patens) bioreactor cultures. Plant Cell Rep., 20, 1135-1140.
44. Lucumi, H. and Alexander, S. (2007) Prozesstechnische Optimierung des Molecular Farming Glykosylierter Proteine in Photo-Bioreaktoren mit dem Moos Physcomitrella patens, Dissertation, University of Karlsruhe.
45. Cerff, M., Wagner, I., Kipf, E., Radtke, C. et al. (2009) Kinetische Untersuchungen zum Wachstum des Mooses Physcomitrella patens untervers chieden en Lichtbe dingungen. Chem. Ing. Tech., 81, 1293-1294.
46. Cerff, M. and Posten, C. (2012) Enhancing the growth of Physcomitrella patens by combination of monochromatic red and blue light-a kinetic study. Biotechnol. J., 7, 527-536.
47. Cerff, M. and Posten, C. (2012) Relationship between light intensity and morphology of the moss Physcomitrella patens in a draft tube photo bioreactor. Biochem. Eng. J., 60, 119-126.
48. Nitsch, J.P. (1951) Growth and development in vitro of excised ovaries. Am. J. Bot., 38, 566.
49. Hangarter, R.P. and Stasinopoulos, T.C. (1991) Effect of Fe-catalyzed photooxidation of EDTA on root growth in plant culture media. Plant Physiol., 96, 843-847.
50. Stengel, E. (1970) The changes in various iron compounds in culture media for algae. Arch. Hydrobiol., 38, 151-169.
51. Pamukcoglu, T. (2009) Arisk-based approach to establishing animal-component-free facilities. BioProcess Int., 7, 54-57.
52. Eaton, LC. (1995) Host cell contaminant protein assay development for recombinant biopharmaceuticals. J. Chromatogr. A, 705, 105-114.
53. Boyd, P., Hall, J., and Cove, D. (1988) An airlift fermentor for the culture of the moss Physcomitrella patens. Proc. Bryol. Methods Workshop, 41-45.
54. Cove, D.J., Knight, C.D., and Lamparter, T. (1997) Mosses as model systems. Trends Plant Sci., 2, 99-105.
55. Perner-Nochta, I., Lucumi, A., and Posten, C. (2007) Photoautotrophic cell and tissue culture in a tubular photobioreactor. Eng. Life Sci., 7, 127-135.
56. Lucumi, A., Posten, C., and Pons, M.-N. (2005) Image analysis supported moss cell disruption in photo-bioreactors. Plant Biol., 7, 276-282.
57. Schüssler, S., Gaul, I., Kuppelmaier, H., and Proper, G. (2011) Polymer compound for photobioreactors. Patent WO2011012397A1.
58. Stomp, A.-M. (2005) The duckweeds: a valuable plant for biomanufacturing. Biotechnol. Annu. Rev., 11, 69-99.
59. Landolt, E. (1993) Lemnaceae, in Flora of North America North of Mexico (ed. Flora of North America Editorial Committee 1993+), vol. 22, p. 148.
60. De Leede, L.G.J., Humphries, J.E., Bechet, A.C., Van Hoogdalem, E.J. et al. (2008) Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial. J. Interf. Cytokine Res. Off. J. Int. Soc. Interf. Cytokine Res., 28, 113-122.
61. Dickey, L.F. (2012) LEX System Overview, http://www.molecularfarming.org/FA0804_Dickey_Warsaw_2012.pdf
62. Dickey, L.F., Cox, K.M., and Peele, C.G. (2012) Expression control elements from the Lemnaceae family, http://www.google .de/patents?id1/4FeH3AQAAEBAJ.
63. McCarthy, A.A. (2005) Biolex, Inc.: pharmaceutical production in plants. Chem. Biol., 12, 141-142.
64. Bevan, M. (1984) Binary agrobacterium vectors for plant transformation. Nucleic Acids Res., 12, 8711-8721.
65. Hoekema, A., Hirsch, P.R., Hooykaas, P.J. J., and Schilperoort, R.A. (1983) A binary plant vector strategy based on separation of vir-and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature, 303, 179-180.
66. Valentine, L. (2003) Agrobacterium tumefaciens and the plant: the David and Goliath of modern genetics. Plant Physiol., 133, 948-955.
67. Everett, K.M., Dickey, L.F., Parsons, J., Loranger, R. et al. (2012) Development of a plant-made pharmaceutical production platform. Bioprocess Int., 10 (1), 16-25.
68. Branson, R.E., Everett, K., Hester, B., and Vickers, T.B. (2007) Bioreactor for growing biological materials supported on a liquid surface. Patent WO2004108881 A2
69. Everett, K.M., Dickey, L.F., Parsons, J., Loranger, R., and Wingate, V. (2012) Development of a plant-made pharmaceutical production platform. BioProcess Int., 10 (1), 16-25.
70. Kelley, B. (2009) Industrialization of mAb production technology: The bioprocessing industry at a crossroads. Mabs, 1, 443-452.
71. Sinclair, A. and Monge, M. (2002) Quantitative economic evaluation of single use disposables in bioprocessing. Pharm. Eng., 22, 20-34.
72. Sinclair, A. and Monge, M. (2005) Concept facility based on single-use systems, Part 2. Bioprocess Int., 3. http://www.bioprocessintl .com/multimedia/archive/00078/0309su07_78595a.pdf
73. Levine, H.L., Lilja, J.E., Stock, R., Hummel, H. et al. (2012) Efficient, flexible facilities for the 21st century. BioProcess Int., 10, 20-30.
74. Hodge, G. (2004) Investing in process development. BioProcess J., 3, 31-35.
75. D'Aoust, M.-A., Lerouge, P., Busse, U., Bilodeau, P. et al. (2005) Efficient and Reliable Production of Pharmaceuticals in Alfalfa, in Molecular Farming (eds R. Fischer and S. Schillberg), Wiley-VCH Verlag GmbH, Weinheim, pp. 1-12.
76. Fischer, R., Stoger, E., Schillberg, S., Christou, P. et al. (2004) Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol., 7, 152-158.
77. Spök, A., Twyman, R.M., Fischer, R., Ma, J.K.C. et al. (2008) Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol., 26, 506-517.
78. Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M. et al. (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol. Adv., 30, 434-439.
79. EMEA C (2005) Guideline on the Quality of Biological Active Substances Produced by Stable Transgene Expression in Higher Plants.
80. FDA/USDA (2002) Guidance for Industry: Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals.
81. Bardor, M., Cabrera, G., Stadlmann, J., Lerouge, P. et al. (2009) N-Glycosylation of plant recombinant pharmaceuticals. Methods Mol. Biol. Clifton. Nj., 483, 239-264.
82. Lerouge, P., Bardor, M., Pagny, S., Gomord, V. et al. (2000) N-Glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants towards an humanisation of plant N-glycans. Curr. Pharm. Biotechnol., 1, 347-354.
83. Cox, K.M., Sterling, J.D., Regan, J.T., Gasdaska, J.R. et al. (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol., 24, 1591-1597.